Target intelligence / Profile preview

Potassium channel tetramerization domain-containing protein 1 (KCTD1)

Target
KCTD1
Molecular classification
Other (BTB/POZ domain-containing protein), Scaffold/adaptor protein (not an ion channel or classical receptor)
01

Overview

Potassium channel tetramerization domain-containing protein 1 (**KCTD1**) is a member of the KCTD protein family, which share structural similarity to the tetramerization (T1/BTB) domain of voltage-gated potassium channels but do not function as ion channels themselves[1][3][6]. KCTD1 contains a conserved N-terminal BTB (POZ) domain that mediates protein-protein interactions and oligomerization, most commonly pentamerization[3][6]. The primary functional role of KCTD1—and related family members—involves acting as an adaptor or scaffold, particularly in recruiting substrate proteins for cullin 3 (Cul3) ubiquitin ligase complexes, thereby regulating ubiquitination, proteasomal degradation, and thus cell signaling[1][3]. KCTD1 is essential for neural development and ectodermal/crest cell function, and its mutations can cause congenital malformations such as scalp defects (aplasia cutis)[5][6]. While its precise physiological and pathological mechanisms are still being elucidated, there is currently no evidence that KCTD1 is a direct therapeutic target, nor are there established small-molecule modulators or clinical biomarkers related to its activity[1][6]. Key points: - **Not a classic receptor, enzyme, or channel**—functions as a modulatory scaffold protein via its BTB domain[1][3][6]. - **Regulates protein ubiquitination/degradation** through the cullin 3 ligase complex[1][3]. - **Involved in neurodevelopmental processes** and genetic disorders when mutated[5][6]. - **No known direct-interacting drugs or reported safety concerns**; not currently a drug target. Primary source support: [1][3][5][6].

Other names
BTB/POZ domain-containing protein KCTD1C18orf5KCTD1Potassium channel tetramerization domain-containing protein 1
02

Biological functions

Protein ubiquitination and degradationCell proliferationDifferentiationApoptosisNeural developmentTranscriptional repression
03

Disease associations

Neurodevelopmental diseaseAplasia cutisOther (mutations implicated in human malformations)

Beyond the preview

Go deeper on Potassium channel tetramerization domain-containing protein 1 (KCTD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel tetramerization domain-containing protein 1 (KCTD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call